Gut microbiota in ALS: possible role in pathogenesis?

References

• Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377:162–172.
   PubMed Web of Science ®Google Scholar
• McCombe PA, Henderson RD. Effects of gender in amyotrophic lateral sclerosis. Gend Med. 2010;7:557–570.
   PubMed Web of Science ®Google Scholar
• McCombe PA, Wray NR, Henderson RD. Extra-motor abnormalities in amyotrophic lateral sclerosis: another layer of heterogeneity. Expert Rev Neurother. 2017 Jun;17(6):561-577. doi: 10.1080/14737175.2017.1273772.
   Google Scholar
• Xu Z, Alruwaili ARS, Henderson RD, et al. Screening for cognitive and behavioural impairment in amyotrophic lateral sclerosis: frequency of abnormality and effect on survival. J Neurol Sci. 2017;376:16–23.
   PubMed Web of Science ®Google Scholar
• Byrne S, Elamin M, Bede P, et al. Absence of consensus in diagnostic criteria for familial neurodegenerative diseases. J Neurol Neurosurg Psychiatry. 2012;83:365–367.
   PubMed Web of Science ®Google Scholar
• Marangi G, Traynor BJ. Genetic causes of amyotrophic lateral sclerosis: new genetic analysis methodologies entailing new opportunities and challenges. Brain Res. 2015;14:75–93.
   Google Scholar
• Renton AE, Chio A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17:17–23.
   PubMed Web of Science ®Google Scholar
• Fang F, Kamel F, Lichtenstein P, et al. Familial aggregation of amyotrophic lateral sclerosis. Ann Neurol. 2009;66:94–99.
   PubMed Web of Science ®Google Scholar
• Al-Chalabi A, Calvo A, Chio A, et al. Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Lancet Neurol. 2014;13:1108–1113.
   PubMed Web of Science ®Google Scholar
• Chio A, Mazzini L, D’Alfonso S, et al. The multistep hypothesis of ALS revisited: the role of genetic mutations. Neurology. 2018;91:e635–e42.
   PubMed Web of Science ®Google Scholar
• Lattante S, Conte A, Zollino M, et al. Contribution of major amyotrophic lateral sclerosis genes to the etiology of sporadic disease. Neurology. 2012;79:66–72.
   PubMed Web of Science ®Google Scholar
• Al-Chalabi A, Fang F, Hanby MF, et al. An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry. 2010;81:1324–1326.
   PubMed Web of Science ®Google Scholar
• Blokhuis AM, Groen EJ, Koppers M, et al. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol. 2013;125:777–794.
   PubMed Web of Science ®Google Scholar
• Hardiman O, Al-Chalabi A, Chio A, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071.
   PubMed Web of Science ®Google Scholar
• Saberi S, Stauffer JE, Schulte DJ, et al. Neuropathology of amyotrophic lateral sclerosis and its variants. Neurol Clin. 2015;33:855–876.
   PubMed Web of Science ®Google Scholar
• Lee YB, Baskaran P, Gomez-Deza J, et al. C9orf72 poly GA RAN-translated protein plays a key role in amyotrophic lateral sclerosis via aggregation and toxicity. Hum Mol Genet. 2017;26:4765–4777.
   PubMed Web of Science ®Google Scholar
• Ayers JI, Cashman NR. Prion-like mechanisms in amyotrophic lateral sclerosis. Handb Clin Neurol. 2018;153:337–354.
   PubMedGoogle Scholar
• Maniecka Z, Polymenidou M. From nucleation to widespread propagation: A prion-like concept for ALS. Virus Res. 2015;207:94–105.
   PubMed Web of Science ®Google Scholar
• Oeckl P, Weydt P, Steinacker P, et al. Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase. J Neurol Neurosurg Psychiatry. 2019;90:4–10.
   PubMed Web of Science ®Google Scholar
• Serio A, Patani R. Concise review: the cellular conspiracy of amyotrophic lateral sclerosis. Stem Cells. 2018;36:293–303.
   PubMed Web of Science ®Google Scholar
• Yamanaka K, Komine O. The multi-dimensional roles of astrocytes in ALS. Neurosci Res. 2018;126:31–38.
   PubMed Web of Science ®Google Scholar
• Ioannides ZA, Ngo ST, Henderson RD, et al. Altered metabolic homeostasis in amyotrophic lateral sclerosis: mechanisms of energy imbalance and contribution to disease progression. Neurodegener Dis. 2016;16:382–397.
   PubMed Web of Science ®Google Scholar
• McCombe PA, Henderson RD. The role of immune and inflammatory mechanisms in ALS. Curr Mol Med. 2011;11:246–254.
   PubMed Web of Science ®Google Scholar
• Ingre C, Roos PM, Piehl F, et al. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015;7:181–193.
   PubMed Web of Science ®Google Scholar
• Banack SA, Cox PA. Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam. Neurology. 2003;61:387–389.
   PubMed Web of Science ®Google Scholar
• Murch SJ, Cox PA, Banack SA, et al. Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam. Acta Neurol Scand. 2004;110:267–269.
   PubMed Web of Science ®Google Scholar
• Roberts AL, Johnson NJ, Cudkowicz ME, et al. Job-related formaldehyde exposure and ALS mortality in the USA. J Neurol Neurosurg Psychiatry. 2016;87:786–788.
   PubMed Web of Science ®Google Scholar
• Weisskopf MG, Morozova N, O’Reilly EJ, et al. Prospective study of chemical exposures and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2009;80:558–561.
   PubMed Web of Science ®Google Scholar
• Khanna S, Tosh PK. A clinician’s primer on the role of the microbiome in human health and disease. Mayo Clin Proc. 2014;89:107–114.
   PubMed Web of Science ®Google Scholar
• Baquero F, Nombela C. The microbiome as a human organ. Clin Microbiol Infect. 2012;18(Suppl 4):2–4.
   PubMed Web of Science ®Google Scholar
• Benias PC, Wells RG, Sackey-Aboagye B, et al. Structure and distribution of an unrecognized interstitium in human tissues. Sci Rep. 2018;8:4947.
   PubMed Web of Science ®Google Scholar
• Wang Y, Kasper LH. The role of microbiome in central nervous system disorders. Brain Behav Immun. 2014;38:1–12.
   PubMed Web of Science ®Google Scholar
• Scheperjans F, Aho V, Pereira PA, et al. Gut microbiota are related to Parkinson’s disease and clinical phenotype. Mov Disord. 2015;30:350–358.
   PubMed Web of Science ®Google Scholar
• Wright ML, Fournier C, Houser MC, et al. Potential role of the gut microbiome in ALS: a systematic review. Biol Res Nurs. 2018;20:513–521.
   PubMed Web of Science ®Google Scholar
• Gill SR, Pop M, Deboy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312:1355–1359.
   PubMed Web of Science ®Google Scholar
• Vanderhaeghen S, Lacroix C, Schwab C. Methanogen communities in stools of humans of different age and health status and co-occurrence with bacteria. FEMS Microbiol Lett. 2015;362:fnv092.
   PubMed Web of Science ®Google Scholar
• Levitt MD, Furne JK, Kuskowski M, et al. Stability of human methanogenic flora over 35 years and a review of insights obtained from breath methane measurements. Clin Gastroenterol Hepatol. 2006;4:123–129.
   PubMed Web of Science ®Google Scholar
• Consortium HMP. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207–214.
   PubMed Web of Science ®Google Scholar
• Hooks KB, O’Malley MA, Davies JE. Dysbiosis and its discontents. MBio. 2017;8:pii: e01492–17.
   PubMed Web of Science ®Google Scholar
• Petersen C, Round JL. Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol. 2014;16:1024–1033.
   PubMed Web of Science ®Google Scholar
• Sundin OH, Mendoza-Ladd A, Morales E, et al. Does a glucose-based hydrogen and methane breath test detect bacterial overgrowth in the jejunum? Neurogastroenterol Motil. 2018 Nov;30(11):e13350. doi: 10.1111/nmo.13350.
   Google Scholar
• Lord RS, Bralley JA. Clinical applications of urinary organic acids. Part 2. Dysbiosis markers. Altern Med Rev. 2008;13:292–306.
   PubMedGoogle Scholar
• Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J. 2017;474:1823–1836.
   PubMed Web of Science ®Google Scholar
• Heintz-Buschart A, Wilmes P. Human gut microbiome: function matters. Trends Microbiol. 2018;26:563–574.
   PubMed Web of Science ®Google Scholar
• Selber-Hnatiw S, Rukundo B, Ahmadi M, et al. Human gut microbiota: toward an ecology of disease. Front Microbiol. 2017;8:1265.
   PubMed Web of Science ®Google Scholar
• Manaka A, Tokue Y, Murakami M. Comparison of 16S ribosomal RNA gene sequence analysis and conventional culture in the environmental survey of a hospital. J Pharm Health Care Sci. 2017;3:8.
   PubMed Web of Science ®Google Scholar
• Knight R, Vrbanac A, Taylor BC, et al. Best practices for analysing microbiomes. Nat Rev Microbiol. 2018;16:410–422.
   PubMed Web of Science ®Google Scholar
• Poretsky R, Rodriguez RL, Luo C, et al. Strengths and limitations of 16S rRNA gene amplicon sequencing in revealing temporal microbial community dynamics. PLoS One. 2014;9:e93827.
   PubMed Web of Science ®Google Scholar
• Gohl DM, Vangay P, Garbe J, et al. Systematic improvement of amplicon marker gene methods for increased accuracy in microbiome studies. Nat Biotechnol. 2016;34:942–949.
   PubMed Web of Science ®Google Scholar
• Vollmers J, Wiegand S, Kaster AK. Comparing and evaluating metagenome assembly tools from a microbiologist’s perspective - not only size matters! PLoS One. 2017;12:e0169662.
   PubMed Web of Science ®Google Scholar
• Brooks JP, Edwards DJ, Harwich MD Jr., et al. The truth about metagenomics: quantifying and counteracting bias in 16S rRNA studies. BMC Microbiol. 2015;15:66.
   PubMed Web of Science ®Google Scholar
• Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7:335–336.
   PubMed Web of Science ®Google Scholar
• Navas-Molina JA, Peralta-Sanchez JM, Gonzalez A, et al. Advancing our understanding of the human microbiome using QIIME. Methods Enzymol. 2013;531:371–444.
   PubMed Web of Science ®Google Scholar
• Callahan BJ, McMurdie PJ, Rosen MJ, et al. DADA2: high-resolution sample inference from illumina amplicon data. Nat Methods. 2016;13:581–583.
   PubMed Web of Science ®Google Scholar
• Callahan BJ, McMurdie PJ, Holmes SP. Exact sequence variants should replace operational taxonomic units in marker-gene data analysis. Isme J. 2017;11:2639–2643.
   PubMed Web of Science ®Google Scholar
• Amir A, McDonald D, Navas-Molina JA, et al. Deblur rapidly resolves single-nucleotide community sequence patterns. mSystems. 2017;2:pii: e00191–16.
   Web of Science ®Google Scholar
• Cole JR, Wang Q, Fish JA, et al. Ribosomal database project: data and tools for high throughput rRNA analysis. Nucleic Acids Res. 2014;42:D633–42.
   PubMed Web of Science ®Google Scholar
• DeSantis TZ, Hugenholtz P, Larsen N, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 2006;72:5069–5072.
   PubMed Web of Science ®Google Scholar
• Quast C, Pruesse E, Yilmaz P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41:D590–6.
   PubMed Web of Science ®Google Scholar
• Weiss S, Xu ZZ, Peddada S, et al. Normalization and microbial differential abundance strategies depend upon data characteristics. Microbiome. 2017;5:27.
   PubMed Web of Science ®Google Scholar
• Langille MG, Zaneveld J, Caporaso JG, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. 2013;31:814–821.
   PubMed Web of Science ®Google Scholar
• Lloyd-Price J, Mahurkar A, Rahnavard G, et al. Strains, functions and dynamics in the expanded human microbiome project. Nature. 2017;550:61–66.
   PubMed Web of Science ®Google Scholar
• Wang J, Jia H. Metagenome-wide association studies: fine-mining the microbiome. Nat Rev Microbiol. 2016;14:508–522.
   PubMed Web of Science ®Google Scholar
• Jovel J, Patterson J, Wang W, et al. Characterization of the gut microbiome using 16S or shotgun metagenomics. Front Microbiol. 2016;7:459.
   PubMed Web of Science ®Google Scholar
• Sharpton TJ. An introduction to the analysis of shotgun metagenomic data. Front Plant Sci. 2014;5:209.
   PubMed Web of Science ®Google Scholar
• Ni J, Yan Q, Yu Y. How much metagenomic sequencing is enough to achieve a given goal? Sci Rep. 2013;3:1968.
   PubMed Web of Science ®Google Scholar
• Medema MH, Blin K, Cimermancic P, et al. antiSMASH: rapid identification, annotation and analysis of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome sequences. Nucleic Acids Res. 2011;39:W339–46.
   PubMed Web of Science ®Google Scholar
• Blin K, Wolf T, Chevrette MG, et al. antiSMASH 4.0-improvements in chemistry prediction and gene cluster boundary identification. Nucleic Acids Res. 2017;45:W36–w41.
   PubMed Web of Science ®Google Scholar
• Fondi M, Lio P. Genome-scale metabolic network reconstruction. Methods Mol Biol. 2015;1231:233–256.
   PubMedGoogle Scholar
• O’Leary NA, Wright MW, Brister JR, et al. Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res. 2016;44:D733–45.
   PubMed Web of Science ®Google Scholar
• Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59–65.
   PubMed Web of Science ®Google Scholar
• Finn RD, Bateman A, Clements J, et al. Pfam: the protein families database. Nucleic Acids Res. 2014;42:D222–30.
   PubMed Web of Science ®Google Scholar
• Suzek BE, Wang Y, Huang H, et al. UniRef clusters: a comprehensive and scalable alternative for improving sequence similarity searches. Bioinformatics. 2015;31:926–932.
   PubMed Web of Science ®Google Scholar
• Huson DH, Beier S, Flade I, et al. MEGAN community edition - interactive exploration and analysis of large-scale microbiome sequencing data. PLoS Comput Biol. 2016;12:e1004957.
   PubMed Web of Science ®Google Scholar
• Wood DE, Salzberg SL. Kraken: ultrafast metagenomic sequence classification using exact alignments. Genome Biol. 2014;15:R46.
   PubMed Web of Science ®Google Scholar
• Truong DT, Franzosa EA, Tickle TL, et al. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat Methods. 2015;12:902–903.
   PubMed Web of Science ®Google Scholar
• Nguyen NP, Mirarab S, Liu B, et al. TIPP: taxonomic identification and phylogenetic profiling. Bioinformatics. 2014;30:3548–3555.
   PubMed Web of Science ®Google Scholar
• Abubucker S, Segata N, Goll J, et al. Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput Biol. 2012;8:e1002358.
   PubMed Web of Science ®Google Scholar
• Nurk S, Meleshko D, Korobeynikov A, et al. metaSPAdes: a new versatile metagenomic assembler. Genome Res. 2017;27:824–834.
   PubMed Web of Science ®Google Scholar
• Namiki T, Hachiya T, Tanaka H, et al. MetaVelvet: an extension of Velvet assembler to de novo metagenome assembly from short sequence reads. Nucleic Acids Res. 2012;40:e155.
   PubMed Web of Science ®Google Scholar
• Li D, Luo R, Liu CM, et al. MEGAHIT v1.0: a fast and scalable metagenome assembler driven by advanced methodologies and community practices. Methods. 2016;102:3–11.
   PubMed Web of Science ®Google Scholar
• Wu YW, Simmons BA, Singer SW. MaxBin 2.0: an automated binning algorithm to recover genomes from multiple metagenomic datasets. Bioinformatics. 2016;32:605–607.
   PubMed Web of Science ®Google Scholar
• Alneberg J, Bjarnason BS, de Bruijn I, et al. Binning metagenomic contigs by coverage and composition. Nat Methods. 2014;11:1144–1146.
   PubMed Web of Science ®Google Scholar
• Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139–140.
   PubMed Web of Science ®Google Scholar
• Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
   PubMed Web of Science ®Google Scholar
• Barwell LJ, Isaac NJ, Kunin WE. Measuring beta-diversity with species abundance data. J Anim Ecol. 2015;84:1112–1122.
   PubMed Web of Science ®Google Scholar
• Bray JRC, Curtis JT. An ordination of the upland forest communities of Southern Wisconsin. Ecol Monogr. 1957;27:325–349.
   Web of Science ®Google Scholar
• Lozupone CA, Hamady M, Kelley ST, et al. Quantitative and qualitative beta diversity measures lead to different insights into factors that structure microbial communities. Appl Environ Microbiol. 2007;73:1576–1585.
   PubMed Web of Science ®Google Scholar
• Real RV, Vargas JM, Olmstead R. The probabilistic basis of Jaccard’s index of similarity. Syst Biol. 1996;45:380–385.
   Web of Science ®Google Scholar
• Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol. 2005;71:8228–8235.
   PubMed Web of Science ®Google Scholar
• Golob JL, Margolis E, Hoffman NG, et al. Evaluating the accuracy of amplicon-based microbiome computational pipelines on simulated human gut microbial communities. BMC Bioinformatics. 2017;18:283.
   PubMed Web of Science ®Google Scholar
• Schloss PD, Westcott SL, Ryabin T, et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 2009;75:7537–7541.
   PubMed Web of Science ®Google Scholar
• Dixon P. VEGAN, a package of R functions for comminity ecology. J Veg Sci. 2003;14:927–930.
   Web of Science ®Google Scholar
• McDonald D, Clemente JC, Kuczynski J, et al. The biological observation matrix (BIOM) format or: how I learned to stop worrying and love the ome-ome. GigaScience. 2012;1:2047-217X-1–7–217X-1–7.
   PubMed Web of Science ®Google Scholar
• Li H. Microbiome, metagenomics and high-dimensional compositional data analysis. Annu Rev Stat Appl. 2015;2:73–94.
   Web of Science ®Google Scholar
• Mandal S, Van Treuren W, White RA, et al. Analysis of composition of microbiomes: a novel method for studying microbial composition. Microb Ecol Health Dis. 2015;26:27663.
   PubMedGoogle Scholar
• Morton JT, Sanders J, Quinn RA, et al. Balance trees reveal microbial niche differentiation. mSystems. 2017;2:piii: e00162–16.
   Web of Science ®Google Scholar
• Aguiar-Pulido V, Huang W, Suarez-Ulloa V, et al. Metagenomics, metatranscriptomics, and metabolomics approaches for microbiome analysis. Evol Bioinform Online. 2016;12:5–16.
   PubMed Web of Science ®Google Scholar
• Lagier JC, Dubourg G, Million M, et al. Culturing the human microbiota and culturomics. Nat Rev Microbiol. 2018;16:540–550.
   PubMed Web of Science ®Google Scholar
• Abu-Ali GS, Mehta RS, Lloyd-Price J, et al. Metatranscriptome of human faecal microbial communities in a cohort of adult men. Nat Microbiol. 2018;3:356–366.
   PubMed Web of Science ®Google Scholar
• Schirmer M, Franzosa EA, Lloyd-Price J, et al. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome. Nat Microbiol. 2018;3:337–346.
   PubMed Web of Science ®Google Scholar
• Wang WL, Xu SY, Ren ZG, et al. Application of metagenomics in the human gut microbiome. World J Gastroenterol. 2015;21:803–814.
   PubMed Web of Science ®Google Scholar
• Martinez X, Pozuelo M, Pascal V, et al. MetaTrans: an open-source pipeline for metatranscriptomics. Sci Rep. 2016;6:26447.
   PubMed Web of Science ®Google Scholar
• Wilmes P, Heintz-Buschart A, Bond PL. A decade of metaproteomics: where we stand and what the future holds. Proteomics. 2015;15:3409–3417.
   PubMed Web of Science ®Google Scholar
• Erickson AR, Cantarel BL, Lamendella R, et al. Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn’s disease. PLoS One. 2012;7:e49138.
   PubMed Web of Science ®Google Scholar
• Heyer R, Schallert K, Zoun R, et al. Challenges and perspectives of metaproteomic data analysis. J Biotechnol. 2017;261:24–36.
   PubMed Web of Science ®Google Scholar
• Rechenberger J, Samaras P, Jarzab A, et al. Challenges in clinical metaproteomics highlighted by the analysis of acute leukemia patients with gut colonization by multidrug-resistant enterobacteriaceae. Proteomes. 2019;7.
   PubMed Web of Science ®Google Scholar
• Lai LA, Tong Z, Chen R, et al. Metaproteomics study of the gut microbiome. Methods Mol Biol. 2019;1871:123–132.
   PubMedGoogle Scholar
• Lagier JC, Khelaifia S, Alou MT, et al. Culture of previously uncultured members of the human gut microbiota by culturomics. Nat Microbiol. 2016;1:16203.
   PubMed Web of Science ®Google Scholar
• Amrane S, Raoult D, Lagier JC. Metagenomics, culturomics, and the human gut microbiota. Expert Rev Anti Infect Ther. 2018;16:373–375.
   PubMed Web of Science ®Google Scholar
• Cassir N, Benamar S, Khalil JB, et al. Clostridium butyricum strains and dysbiosis linked to necrotizing enterocolitis in preterm neonates. Clin Infect Dis. 2015;61:1107–1115.
   PubMed Web of Science ®Google Scholar
• Kilian M, Chapple IL, Hannig M, et al. The oral microbiome - an update for oral healthcare professionals. Br Dent J. 2016;221:657–666.
   PubMed Web of Science ®Google Scholar
• Moran C, Sheehan D, Shanahan F. The small bowel microbiota. Curr Opin Gastroenterol. 2015;31:130–136.
   PubMed Web of Science ®Google Scholar
• Zmora N, Zilberman-Schapira G, Suez J, et al. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell. 2018;174:1388–405.e21.
   PubMed Web of Science ®Google Scholar
• Mariat D, Firmesse O, Levenez F, et al. The firmicutes/bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 2009;9:123.
   PubMed Web of Science ®Google Scholar
• Li Q, Lauber CL, Czarnecki-Maulden G, et al. Effects of the dietary protein and carbohydrate ratio on gut microbiomes in dogs of different body conditions. MBio. 2017;8:piii: e01703–16.
   Web of Science ®Google Scholar
• Jandhyala SM, Talukdar R, Subramanyam C, et al. Role of the normal gut microbiota. World J Gastroenterol. 2015;21:8787–8803.
   PubMed Web of Science ®Google Scholar
• Requena T, Martinez-Cuesta MC, Pelaez C. Diet and microbiota linked in health and disease. Food Funct. 2018;9:688–704.
   PubMed Web of Science ®Google Scholar
• Haro C, Rangel-Zuniga OA, Alcala-Diaz JF, et al. Intestinal microbiota is influenced by gender and body mass index. PLoS One. 2016;11:e0154090.
   PubMed Web of Science ®Google Scholar
• Goodrich JK, Davenport ER, Beaumont M, et al. Genetic determinants of the gut microbiome in UK twins. Cell Host Microbe. 2016;19:731–743.
   PubMed Web of Science ®Google Scholar
• Rothschild D, Weissbrod O, Barkan E, et al. Environment dominates over host genetics in shaping human gut microbiota. Nature. 2018;555:210–215.
   PubMed Web of Science ®Google Scholar
• Kurilshikov A, Wijmenga C, Fu J, et al. Host genetics and gut microbiome: challenges and perspectives. Trends Immunol. 2017;38:633–647.
   PubMed Web of Science ®Google Scholar
• Koliada A, Syzenko G, Moseiko V, et al. Association between body mass index and firmicutes/bacteroidetes ratio in an adult Ukrainian population. BMC Microbiol. 2017;17:120.
   PubMed Web of Science ®Google Scholar
• Lynn MA, Tumes DJ, Choo JM, et al. Early-life antibiotic-driven dysbiosis leads to dysregulated vaccine immune responses in mice. Cell Host Microbe. 2018;23:653–60.e5.
   PubMed Web of Science ®Google Scholar
• Vrieze A, Out C, Fuentes S, et al. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. J Hepatol. 2014;60:824–831.
   PubMed Web of Science ®Google Scholar
• Maier L, Pruteanu M, Kuhn M, et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature. 2018;555:623–628.
   PubMed Web of Science ®Google Scholar
• Alvarez CS, Badia J, Bosch M, et al. Outer membrane vesicles and soluble factors released by probiotic escherichia coli Nissle 1917 and commensal ECOR63 enhance barrier function by regulating expression of tight junction proteins in intestinal epithelial cells. Front Microbiol. 2016;7:1981.
   PubMed Web of Science ®Google Scholar
• Rahman K, Desai C, Iyer SS, et al. Loss of junctional adhesion molecule a promotes severe steatohepatitis in mice on a diet high in saturated fat, fructose, and cholesterol. Gastroenterology. 2016;151:733–46.e12.
   PubMed Web of Science ®Google Scholar
• Shen L, Su L, Turner JR. Mechanisms and functional implications of intestinal barrier defects. Dig Dis. 2009;27:443–449.
   PubMed Web of Science ®Google Scholar
• Turner JR. Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application. Am J Pathol. 2006;169:1901–1909.
   PubMed Web of Science ®Google Scholar
• Al-Asmakh M, Hedin L. Microbiota and the control of blood-tissue barriers. Tissue Barriers. 2015;3:e1039691.
   PubMed Web of Science ®Google Scholar
• Fukui H. Increased intestinal permeability and decreased barrier function: does it really influence the risk of inflammation? Inflamm Intest Dis. 2016;1:135–145.
   PubMedGoogle Scholar
• Maslowski KM, Mackay CR. Diet, gut microbiota and immune responses. Nat Immunol. 2011;12:5–9.
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Gordon JI. The core gut microbiome, energy balance and obesity. J Physiol. 2009;587:4153–4158.
   PubMed Web of Science ®Google Scholar
• Sonnenburg JL, Backhed F. Diet-microbiota interactions as moderators of human metabolism. Nature. 2016;535:56–64.
   PubMed Web of Science ®Google Scholar
• Morowitz MJ, Carlisle EM, Alverdy JC. Contributions of intestinal bacteria to nutrition and metabolism in the critically ill. Surg Clin North Am. 2011;91:771–85,viii.
   PubMed Web of Science ®Google Scholar
• Payne AN, Chassard C, Zimmermann M, et al. The metabolic activity of gut microbiota in obese children is increased compared with normal-weight children and exhibits more exhaustive substrate utilization. Nutr Diabetes. 2011;1:e12.
   PubMed Web of Science ®Google Scholar
• Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest. 2011;121:2126–2132.
   PubMed Web of Science ®Google Scholar
• Ley RE, Backhed F, Turnbaugh P, et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005;102:11070–11075.
   PubMed Web of Science ®Google Scholar
• Ley RE, Turnbaugh PJ, Klein S, et al. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444:1022–1023.
   PubMed Web of Science ®Google Scholar
• Gomes AC, Hoffmann C, Mota JF. The human gut microbiota: metabolism and perspective in obesity. Gut Microbes. 2018;9:308–325.
   PubMed Web of Science ®Google Scholar
• Ghazalpour A, Cespedes I, Bennett BJ, et al. Expanding role of gut microbiota in lipid metabolism. Curr Opin Lipidol. 2016;27:141–147.
   PubMed Web of Science ®Google Scholar
• Long SL, Gahan CGM, Joyce SA. Interactions between gut bacteria and bile in health and disease. Mol Aspects Med. 2017;56:54–65.
   PubMed Web of Science ®Google Scholar
• Mackie RI, Sghir A, Gaskins HR. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr. 1999;69:1035s–45s.
   PubMed Web of Science ®Google Scholar
• De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A. 2010;107:14691–14696.
   PubMed Web of Science ®Google Scholar
• Suez J, Korem T, Zeevi D, et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature. 2014;514:181–186.
   PubMed Web of Science ®Google Scholar
• Chassaing B, Koren O, Goodrich JK, et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature. 2015;519:92–96.
   PubMed Web of Science ®Google Scholar
• Fei N, Zhao L. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. Isme J. 2013;7:880–884.
   PubMed Web of Science ®Google Scholar
• Ahluwalia B, Magnusson MK, Ohman L. Mucosal immune system of the gastrointestinal tract: maintaining balance between the good and the bad. Scand J Gastroenterol. 2017;52:1185–1193.
   PubMed Web of Science ®Google Scholar
• Mason KL, Huffnagle GB, Noverr MC, et al. Overview of gut immunology. Adv Exp Med Biol. 2008;635:1–14.
   PubMed Web of Science ®Google Scholar
• Huang Y, Mao K, Germain RN. Thinking differently about ILCs-not just tissue resident and not just the same as CD4(+) T-cell effectors. Immunol Rev. 2018;286:160–171.
   PubMed Web of Science ®Google Scholar
• Commins SP. Mechanisms of oral tolerance. Pediatr Clin North Am. 2015;62:1523–1529.
   PubMed Web of Science ®Google Scholar
• Tomkovich S, Jobin C. Microbiota and host immune responses: a love-hate relationship. Immunology. 2016;147:1–10.
   PubMed Web of Science ®Google Scholar
• Goverse G, Molenaar R, Macia L, et al. Diet-derived short chain fatty acids stimulate intestinal epithelial cells to induce mucosal tolerogenic dendritic cells. J Immunol. 2017;198:2172–2181.
   PubMed Web of Science ®Google Scholar
• Kranich J, Maslowski KM, Mackay CR. Commensal flora and the regulation of inflammatory and autoimmune responses. Semin Immunol. 2011;23:139–145.
   PubMed Web of Science ®Google Scholar
• Rizzetto L, Fava F, Tuohy KM, et al. Connecting the immune system, systemic chronic inflammation and the gut microbiome: the role of sex. J Autoimmun. 2018;92:12–34.
   PubMed Web of Science ®Google Scholar
• Rosser EC, Mauri C. A clinical update on the significance of the gut microbiota in systemic autoimmunity. J Autoimmun. 2016;74:85–93.
   PubMed Web of Science ®Google Scholar
• Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157:121–141.
   PubMed Web of Science ®Google Scholar
• Vatanen T, Kostic AD, d’Hennezel E, et al. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell. 2016;165:842–853.
   PubMed Web of Science ®Google Scholar
• Lee N, Kim WU. Microbiota in T-cell homeostasis and inflammatory diseases. Exp Mol Med. 2017;49:e340.
   PubMed Web of Science ®Google Scholar
• Petta I, Fraussen J, Somers V, et al. Interrelation of diet, gut microbiome, and autoantibody production. Front Immunol. 2018;9:439.
   PubMed Web of Science ®Google Scholar
• Sayin SI, Wahlstrom A, Felin J, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 2013;17:225–235.
   PubMed Web of Science ®Google Scholar
• Wahlstrom A, Sayin SI, Marschall HU, et al. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 2016;24:41–50.
   PubMed Web of Science ®Google Scholar
• Costa M, Brookes SJ, Hennig GW. Anatomy and physiology of the enteric nervous system. Gut. 2000;47(Suppl 4):iv15–9; discussion iv26.
   Google Scholar
• Carabotti M, Scirocco A, Maselli MA, et al. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015;28:203–209.
   PubMed Web of Science ®Google Scholar
• Kaelberer MM, Buchanan KL, Klein ME, et al. A gut-brain neural circuit for nutrient sensory transduction. Science. 2018;361:piii:eaat5236.
   PubMed Web of Science ®Google Scholar
• Guo Y, Wang Q, Zhang K, et al. HO-1 induction in motor cortex and intestinal dysfunction in TDP-43 A315T transgenic mice. Brain Res. 2012;1460:88–95.
   PubMed Web of Science ®Google Scholar
• Esmaeili MA, Panahi M, Yadav S, et al. Premature death of TDP-43 (A315T) transgenic mice due to gastrointestinal complications prior to development of full neurological symptoms of amyotrophic lateral sclerosis. Int J Exp Pathol. 2013;94:56–64.
   PubMed Web of Science ®Google Scholar
• Hatzipetros T, Bogdanik LP, Tassinari VR, et al. C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS. Brain Res. 2014;1584:59–72.
   PubMed Web of Science ®Google Scholar
• Chandra R, Hiniker A, Kuo YM, et al. alpha-Synuclein in gut endocrine cells and its implications for Parkinson’s disease. JCI Insight. 2017 Jun 15;2(12). pii: 92295. doi: 10.1172/jci.insight.92295.
   Google Scholar
• Lawson VA, Furness JB, Klemm HM, et al. The brain to gut pathway: a possible route of prion transmission. Gut. 2010;59:1643–1651.
   PubMed Web of Science ®Google Scholar
• Kaatz M, Fast C, Ziegler U, et al. Spread of classic BSE prions from the gut via the peripheral nervous system to the brain. Am J Pathol. 2012;181:515–524.
   PubMed Web of Science ®Google Scholar
• Chen Y, Shao Q, Yuan YH, et al. Prion-like propagation of alpha-synuclein in the gut-brain axis. Brain Res Bull. 2018;140:341–346.
   PubMed Web of Science ®Google Scholar
• Bravo JA, Julio-Pieper M, Forsythe P, et al. Communication between gastrointestinal bacteria and the nervous system. Curr Opin Pharmacol. 2012;12:667–672.
   PubMed Web of Science ®Google Scholar
• Kim N, Yun M, Oh YJ, et al. Mind-altering with the gut: modulation of the gut-brain axis with probiotics. J Microbiol. 2018;56:172–182.
   PubMed Web of Science ®Google Scholar
• Sudo N. Microbiome, HPA axis and production of endocrine hormones in the gut. Adv Exp Med Biol. 2014;817:177–194.
   PubMed Web of Science ®Google Scholar
• Sharon G, Sampson TR, Geschwind DH, et al. The central nervous system and the gut microbiome. Cell. 2016;167:915–932.
   PubMed Web of Science ®Google Scholar
• Clapp M, Aurora N, Herrera L, et al. Gut microbiota’s effect on mental health: the gut-brain axis. Clin Pract. 2017;7:987.
   PubMed Web of Science ®Google Scholar
• Proctor C, Thiennimitr P, Chattipakorn N, et al. Diet, gut microbiota and cognition. Metab Brain Dis. 2017;32:1–17.
   PubMed Web of Science ®Google Scholar
• Daulatzai MA. Chronic functional bowel syndrome enhances gut-brain axis dysfunction, neuroinflammation, cognitive impairment, and vulnerability to dementia. Neurochem Res. 2014;39:624–644.
   PubMed Web of Science ®Google Scholar
• Hoban AE, Stilling RM, Mm G, et al. Microbial regulation of microRNA expression in the amygdala and prefrontal cortex. Microbiome. 2017;5:102.
   PubMed Web of Science ®Google Scholar
• Daulatzai MA. Non-celiac gluten sensitivity triggers gut dysbiosis, neuroinflammation, gut-brain axis dysfunction, and vulnerability for dementia. CNS Neurol Disord Drug Targets. 2015;14:110–131.
   PubMed Web of Science ®Google Scholar
• Lyte M, Chapel A, Lyte JM, et al. Resistant starch alters the microbiota-gut brain axis: implications for dietary modulation of behavior. PLoS One. 2016;11:e0146406.
   PubMed Web of Science ®Google Scholar
• Rothhammer V, Borucki DM, Tjon EC, et al. Microglial control of astrocytes in response to microbial metabolites. Nature. 2018;557:724–728.
   PubMed Web of Science ®Google Scholar
• Scheline RR. Metabolism of foreign compounds by gastrointestinal microorganisms. Pharmacol Rev. 1973;25:451–523.
   PubMed Web of Science ®Google Scholar
• Sousa T, Paterson R, Moore V, et al. The gastrointestinal microbiota as a site for the biotransformation of drugs. Int J Pharm. 2008;363:1–25.
   PubMed Web of Science ®Google Scholar
• Spanogiannopoulos P, Bess EN, Carmody RN, et al. The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat Rev Microbiol. 2016;14:273–287.
   PubMed Web of Science ®Google Scholar
• Xu H, Heinze TM, Paine DD, et al. Sudan azo dyes and Para Red degradation by prevalent bacteria of the human gastrointestinal tract. Anaerobe. 2010;16:114–119.
   PubMed Web of Science ®Google Scholar
• Macholz R, Kujawa M, Schulze J, et al. The metabolism of some xenobiotics in germ-free and conventional rats. Arch Toxicol Suppl. 1985;8:373–376.
   PubMedGoogle Scholar
• Michalke K, Schmidt A, Huber B, et al. Role of intestinal microbiota in transformation of bismuth and other metals and metalloids into volatile methyl and hydride derivatives in humans and mice. Appl Environ Microbiol. 2008;74:3069–3075.
   PubMed Web of Science ®Google Scholar
• Thomas F, Diaz-Bone RA, Wuerfel O, et al. Connection between multimetal(loid) methylation in methanoarchaea and central intermediates of methanogenesis. Appl Environ Microbiol. 2011;77:8669–8675.
   PubMed Web of Science ®Google Scholar
• Ma MK, McLeod HL. Lessons learned from the irinotecan metabolic pathway. Curr Med Chem. 2003;10:41–49.
   PubMed Web of Science ®Google Scholar
• Mathijssen RH, van Alphen RJ, Verweij J, et al. Clinical pharmacokinetics and metabolism of irinotecan (CPT-11). Clin Cancer Res. 2001;7:2182–2194.
   PubMed Web of Science ®Google Scholar
• Kassie F, Rabot S, Kundi M, et al. Intestinal microflora plays a crucial role in the genotoxicity of the cooked food mutagen 2-amino-3-methylimidazo [4,5-f]quinoline. Carcinogenesis. 2001;22:1721–1725.
   PubMed Web of Science ®Google Scholar
• Johnson EA, Bradshaw M. Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective. Toxicon. 2001;39:1703–1722.
   PubMed Web of Science ®Google Scholar
• Ngo ST, Steyn FJ, McCombe PA. Body mass index and dietary intervention: implications for prognosis of amyotrophic lateral sclerosis. J Neurol Sci. 2014;340:5–12.
   PubMed Web of Science ®Google Scholar
• Ngo ST, Mi JD, Henderson RD, et al. Exploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventions. Degener Neurol Neuromuscul Dis. 2017;7:95–108.
   PubMed Web of Science ®Google Scholar
• Ahmed RM, Caga J, Devenney E, et al. Cognition and eating behavior in amyotrophic lateral sclerosis: effect on survival. J Neurol. 2016;263:1593–1603.
   PubMed Web of Science ®Google Scholar
• Bouteloup C, Desport JC, Clavelou P, et al. Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol. 2009;256:1236–1242.
   PubMed Web of Science ®Google Scholar
• Desport JC, Torny F, Lacoste M, et al. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegener Dis. 2005;2:202–207.
   PubMed Web of Science ®Google Scholar
• Funalot B, Desport JC, Sturtz F, et al. High metabolic level in patients with familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:113–117.
   PubMed Web of Science ®Google Scholar
• Steyn FJ, Ioannides ZA, van Eijk RPA, et al. Hypermetabolism in ALS is associated with greater functional decline and shorter survival. J Neurol Neurosurg Psychiatry. 2018;89:1016–1023.
   PubMed Web of Science ®Google Scholar
• Kocelak P, Zak-Golab A, Zahorska-Markiewicz B, et al. Resting energy expenditure and gut microbiota in obese and normal weight subjects. Eur Rev Med Pharmacol Sci. 2013;17:2816–2821.
   PubMed Web of Science ®Google Scholar
• Armougom F, Henry M, Vialettes B, et al. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and methanogens in anorexic patients. PLoS One. 2009;4:e7125.
   PubMed Web of Science ®Google Scholar
• Morita C, Tsuji H, Hata T, et al. Gut dysbiosis in patients with anorexia nervosa. PLoS One. 2015;10:e0145274.
   PubMed Web of Science ®Google Scholar
• Mack I, Cuntz U, Gramer C, et al. Weight gain in anorexia nervosa does not ameliorate the faecal microbiota, branched chain fatty acid profiles, and gastrointestinal complaints. Sci Rep. 2016;6:26752.
   PubMed Web of Science ®Google Scholar
• Ngo ST, van Eijk RPA, Chachay V, van den Berg LH, McCombe PA, Henderson RD, Steyn FJ. Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Scler Frontotemporal Degener. Accepted, May 2019.
   Google Scholar
• Ahmed RM, Dupuis L, Kiernan MC. Paradox of amyotrophic lateral sclerosis and energy metabolism. J Neurol Neurosurg Psychiatry. 2018;89:1013–1014.
   PubMed Web of Science ®Google Scholar
• Beers DR, Zhao W, Wang J, et al. ALS patients’ regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity. JCI Insight. 2017;2:e89530.
   PubMed Web of Science ®Google Scholar
• Sheean RK, McKay FC, Cretney E, et al. Association of regulatory T-cell expansion with progression of amyotrophic lateral sclerosis: a study of humans and a transgenic mouse model. JAMA Neurol. 2018;75:681–689.
   PubMed Web of Science ®Google Scholar
• Henkel JS, Beers DR, Wen S, et al. Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival. EMBO Mol Med. 2013;5:64–79.
   PubMed Web of Science ®Google Scholar
• Zhao W, Beers DR, Hooten KG, et al. Characterization of gene expression phenotype in amyotrophic lateral sclerosis monocytes. JAMA Neurol. 2017;74:677–685.
   PubMed Web of Science ®Google Scholar
• Rusconi M, Gerardi F, Santus W, et al. Inflammatory role of dendritic cells in amyotrophic lateral sclerosis revealed by an analysis of patients’ peripheral blood. Sci Rep. 2017;7:7853.
   PubMed Web of Science ®Google Scholar
• Davis BM, Salinas-Navarro M, Cordeiro MF, et al. Characterizing microglia activation: a spatial statistics approach to maximize information extraction. Sci Rep. 2017;7:1576.
   PubMed Web of Science ®Google Scholar
• Geloso MC, Corvino V, Marchese E, et al. The dual role of microglia in ALS: mechanisms and therapeutic approaches. Front Aging Neurosci. 2017;9:242.
   PubMed Web of Science ®Google Scholar
• Thonhoff JR, Simpson EP, Appel SH. Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis. Curr Opin Neurol. 2018;31:635–639.
   PubMed Web of Science ®Google Scholar
• Lee JD, Kamaruzaman NA, Fung JN, et al. Dysregulation of the complement cascade in the hSOD1G93A transgenic mouse model of amyotrophic lateral sclerosis. J Neuroinflammation. 2013;10:119.
   PubMed Web of Science ®Google Scholar
• Pellegrini C, Antonioli L, Colucci R, et al. Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases? Acta Neuropathol. 2018;136:345–361.
   PubMed Web of Science ®Google Scholar
• Erny D, Hrabe de Angelis AL, Jaitin D, et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci. 2015;18:965–977.
   PubMed Web of Science ®Google Scholar
• Toepfer M, Folwaczny C, Klauser A, et al. Gastrointestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 1999;1:15–19.
   PubMed Web of Science ®Google Scholar
• Toepfer M, Schroeder M, Klauser A, et al. Delayed colonic transit times in amyotrophic lateral sclerosis assessed with radio-opaque markers. Eur J Med Res. 1997;2:473–476.
   PubMedGoogle Scholar
• Toepfer M, Folwaczny C, Lochmuller H, et al. Noninvasive (13)C-octanoic acid breath test shows delayed gastric emptying in patients with amyotrophic lateral sclerosis. Digestion. 1999;60:567–571.
   PubMed Web of Science ®Google Scholar
• Nubling GS, Mie E, Bauer RM, et al. Increased prevalence of bladder and intestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:174–179.
   PubMed Web of Science ®Google Scholar
• Carvalho M, Schwartz MS, Swash M. Involvement of the external anal sphincter in amyotrophic lateral sclerosis. Muscle Nerve. 1995;18:848–853.
   PubMed Web of Science ®Google Scholar
• Killinger BA, Labrie V. Vertebrate food products as a potential source of prion-like alpha-synuclein. NPJ Parkinsons Dis. 2017;3:33.
   PubMed Web of Science ®Google Scholar
• Wu S, Yi J, Zhang YG, et al. Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model. Physiol Rep. 2015;3:pii: e12356.
   Web of Science ®Google Scholar
• Rao M, Gershon MD. The bowel and beyond: the enteric nervous system in neurological disorders. Nat Rev Gastroenterol Hepatol. 2016;13:517–528.
   PubMed Web of Science ®Google Scholar
• Williams BB, Van Benschoten AH, Cimermancic P, et al. Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. Cell Host Microbe. 2014;16:495–503.
   PubMed Web of Science ®Google Scholar
• Johnson KV, Foster KR. Why does the microbiome affect behaviour? Nat Rev Microbiol. 2018;16:647–655.
   PubMed Web of Science ®Google Scholar
• Perez-Pardo P, Hartog M, Garssen J, et al. Microbes tickling your tummy: the importance of the gut-brain axis in Parkinson’s disease. Curr Behav Neurosci Rep. 2017;4:361–368.
   PubMedGoogle Scholar
• Dittmann E, Fewer DP, Neilan BA. Cyanobacterial toxins: biosynthetic routes and evolutionary roots. FEMS Microbiol Rev. 2013;37:23–43.
   PubMed Web of Science ®Google Scholar
• Brenner SR. Blue-green algae or cyanobacteria in the intestinal micro-flora may produce neurotoxins such as beta-N-methylamino-L-alanine (BMAA) which may be related to development of amyotrophic lateral sclerosis, Alzheimer’s disease and Parkinson-dementia-complex in humans and equine motor neuron disease in horses. Med Hypotheses. 2013;80:103.
   PubMed Web of Science ®Google Scholar
• Devlin AS, Marcobal A, Dodd D, et al. Modulation of a circulating uremic solute via rational genetic manipulation of the gut microbiota. Cell Host Microbe. 2016;20:709–715.
   PubMed Web of Science ®Google Scholar
• Adesso S, Magnus T, Cuzzocrea S, et al. Indoxyl sulfate affects glial function increasing oxidative stress and neuroinflammation in chronic kidney disease: interaction between astrocytes and microglia. Front Pharmacol. 2017;8:370.
   PubMed Web of Science ®Google Scholar
• Chhibber-Goel J, Gaur A, Singhal V, et al. The complex metabolism of trimethylamine in humans: endogenous and exogenous sources. Expert Rev Mol Med. 2016;18:e8.
   PubMed Web of Science ®Google Scholar
• Fennema D, Phillips IR, Shephard EA. Trimethylamine and trimethylamine N-oxide, a flavin-containing monooxygenase 3 (FMO3)-mediated host-microbiome metabolic axis implicated in health and disease. Drug Metab Dispos. 2016;44:1839–1850.
   PubMed Web of Science ®Google Scholar
• Su T, Monte WC, Hu X, et al. Formaldehyde as a trigger for protein aggregation and potential target for mitigation of age-related, progressive cognitive impairment. Curr Top Med Chem. 2016;16:472–484.
   PubMed Web of Science ®Google Scholar
• Szende B, Tyihak E. Effect of formaldehyde on cell proliferation and death. Cell Biol Int. 2010;34:1273–1282.
   PubMed Web of Science ®Google Scholar
• Dickerson AS, Hansen J, Gredal O, et al. Amyotrophic lateral sclerosis and exposure to diesel exhaust in a Danish cohort. Am J Epidemiol. 2018 epub;187:1613–1622.
   PubMed Web of Science ®Google Scholar
• Pamphlett R, Rikard-Bell A, Ramagopalan S. Different occupations associated with amyotrophic lateral sclerosis: is diesel exhaust the link? PLoS One. 2013;8:e80993.
   PubMed Web of Science ®Google Scholar
• Van de Wiele T, Vanhaecke L, Boeckaert C, et al. Human colon microbiota transform polycyclic aromatic hydrocarbons to estrogenic metabolites. Environ Health Perspect. 2005;113:6–10.
   PubMed Web of Science ®Google Scholar
• Renwick AG, Drasar BS. Environmental carcinogens and large bowel cancer. Nature. 1976;263:234–235.
   PubMed Web of Science ®Google Scholar
• Gao D, Wu M, Wang C, et al. Chronic exposure to low benzo[a]pyrene level causes neurodegenerative disease-like syndromes in zebrafish (Danio rerio). Aquat Toxicol. 2015;167:200–208.
   PubMed Web of Science ®Google Scholar
• Ash PEA, Stanford EA, Al Abdulatif A, et al. Dioxins and related environmental contaminants increase TDP-43 levels. Mol Neurodegener. 2017;12:35.
   PubMed Web of Science ®Google Scholar
• Longstreth WT Jr., Meschke JS, Davidson SK, et al. Hypothesis: a motor neuron toxin produced by a clostridial species residing in gut causes ALS. Med Hypotheses. 2005;64:1153–1156.
   PubMed Web of Science ®Google Scholar
• Lutz C. Mouse models of ALS: past, present and future. Brain Res. 2018;1693:1–10.
   PubMed Web of Science ®Google Scholar
• Elphick DA, Mahida YR. Paneth cells: their role in innate immunity and inflammatory disease. Gut. 2005;54:1802–1809.
   PubMed Web of Science ®Google Scholar
• Zhou J, Sun J. Does the gut drive amyotrophic lateral sclerosis progress? Neurodegener Dis Manag. 2015;5:375–378.
   PubMed Web of Science ®Google Scholar
• Zhang YG, Wu S, Yi J, et al. Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis. Clin Ther. 2017;39:322–336.
   PubMed Web of Science ®Google Scholar
• Fang X, Wang X, Yang S, et al. Evaluation of the microbial diversity in amyotrophic lateral sclerosis using high-throughput sequencing. Front Microbiol. 2016;7:1479.
   PubMed Web of Science ®Google Scholar
• Rowin J, Xia Y, Jung B, et al. Gut inflammation and dysbiosis in human motor neuron disease. Physiol Rep. 2017;5:pii: e13443.
   PubMed Web of Science ®Google Scholar
• Brenner D, Hiergeist A, Adis C, et al. The fecal microbiome of ALS patients. Neurobiol Aging. 2018;61:132–137.
   PubMed Web of Science ®Google Scholar
• Mazzini L, Mogna L, De Marchi F, et al. Potential role of gut microbiota in ALS pathogenesis and possible novel therapeutic strategies. J Clin Gastroenterol. 2018;52(suppl 1):S68–S70.
   PubMedGoogle Scholar
• Rosenfeld J, Ellis A. Nutrition and dietary supplements in motor neuron disease. Phys Med Rehabil Clin N Am. 2008;19:573–589.
   PubMed Web of Science ®Google Scholar
• Almeida CS, Stanich P, Salvioni CC, et al. Assessment and nutrition education in patients with amyotrophic lateral sclerosis. Arq Neuropsiquiatr. 2016;74:902–908.
   PubMed Web of Science ®Google Scholar
• Wills AM, Hubbard J, Macklin EA, et al. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet. 2014;383:2065–2072.
   PubMed Web of Science ®Google Scholar
• Nieves JW, Gennings C, Factor-Litvak P, et al. Association between dietary intake and function in amyotrophic lateral sclerosis. JAMA Neurol. 2016;73:1425–1432.
   PubMed Web of Science ®Google Scholar
• Cortes A, Hadler J, Pointon JP, et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet. 2013;45:730–738.
   PubMed Web of Science ®Google Scholar
• Kim B, Jin Y, Kim SH, et al. Association between macronutrient intake and amyotrophic lateral sclerosis prognosis. Nutr Neurosci. 2018;1–8.
   Google Scholar
• Heiman ML, Greenway FL. A healthy gastrointestinal microbiome is dependent on dietary diversity. Mol Metab. 2016;5:317–320.
   PubMed Web of Science ®Google Scholar
• Maguire M, Maguire G. Gut dysbiosis, leaky gut, and intestinal epithelial proliferation in neurological disorders: towards the development of a new therapeutic using amino acids, prebiotics, probiotics, and postbiotics. Rev Neurosci. 2019 Jan 28;30(2):179-201. doi: 10.1515/revneuro-2018-0024.
   Google Scholar
• Kim M, Friesen L, Park J, et al. Microbial metabolites, short-chain fatty acids, restrain tissue bacterial load, chronic inflammation, and associated cancer in the colon of mice. Eur J Immunol. 2018;48:1235–1247.
   PubMed Web of Science ®Google Scholar
• Tsuei J, Chau T, Mills D, et al. Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer. Exp Biol Med (Maywood). 2014;239:1489–1504.
   PubMed Web of Science ®Google Scholar
• Walsh LK, Restaino RM, Neuringer M, et al. Administration of tauroursodeoxycholic acid prevents endothelial dysfunction caused by an oral glucose load. Clin Sci (Lond). 2016;130:1881–1888.
   PubMed Web of Science ®Google Scholar
• Elia AE, Lalli S, Monsurro MR, et al. Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis. Eur J Neurol. 2016;23:45–52.
   PubMed Web of Science ®Google Scholar
• Brownawell AM, Caers W, Gibson GR, et al. Prebiotics and the health benefits of fiber: current regulatory status, future research, and goals. J Nutr. 2012;142:962–974.
   PubMed Web of Science ®Google Scholar
• Watkins C, Stanton C, Ryan CA, et al. Microbial therapeutics designed for infant health. Front Nutr. 2017;4:48.
   PubMed Web of Science ®Google Scholar
• Nicolucci AC, Hume MP, Martinez I, et al. Prebiotics reduce body fat and alter intestinal microbiota in children who are overweight or with obesity. Gastroenterology. 2017;153:711–722.
   PubMed Web of Science ®Google Scholar
• Pedrolli DB, Ribeiro NV, Squizato PN, et al. Engineering microbial living therapeutics: the synthetic biology toolbox. Trends Biotechnol. 2019;37:100–115.
   PubMed Web of Science ®Google Scholar
• Ettinger G, MacDonald K, Reid G, et al. The influence of the human microbiome and probiotics on cardiovascular health. Gut Microbes. 2014;5:719–728.
   PubMed Web of Science ®Google Scholar
• Severyn CJ, Bhatt AS. With probiotics, resistance is not always futile. Cell Host Microbe. 2018;24:334–336.
   PubMed Web of Science ®Google Scholar
• Gao R, Zhang X, Huang L, et al. Gut microbiota alteration after long-term consumption of probiotics in the elderly. Probiotics Antimicrob Proteins. 2018 epub.
   PubMed Web of Science ®Google Scholar
• Suez J, Zmora N, Zilberman-Schapira G, et al. Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell. 2018;174:1406–23.e16.
   PubMed Web of Science ®Google Scholar
• Lee J, Seto D, Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol. 2008;121:116–21.e11.
   PubMed Web of Science ®Google Scholar
• Guslandi M, Petrone MC, Testoni PA. Rifaximin for active ulcerative colitis. Inflamm Bowel Dis. 2006;12:335.
   PubMed Web of Science ®Google Scholar
• Khelaifia S, Drancourt M. Susceptibility of archaea to antimicrobial agents: applications to clinical microbiology. Clin Microbiol Infect. 2012;18:841–848.
   PubMed Web of Science ®Google Scholar
• Bischoff SC, Barbara G, Buurman W, et al. Intestinal permeability–a new target for disease prevention and therapy. BMC Gastroenterol. 2014;14:189.
   PubMed Web of Science ®Google Scholar
• Odenwald MA, Turner JR. Intestinal permeability defects: is it time to treat? Clin Gastroenterol Hepatol. 2013;11:1075–1083.
   PubMed Web of Science ®Google Scholar
• Kato T, Honda Y, Kurita Y, et al. Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers. PLoS One. 2017;12:e0175626.
   PubMed Web of Science ®Google Scholar
• Bouri S, Hart A. Fecal microbial transplantation: an update. Curr Opin Clin Nutr Metab Care. 2018 Sep;21(5):405-410. doi: 10.1097/MCO.0000000000000488.
   Google Scholar
• Cammarota G, Pecere S, Ianiro G, et al. Principles of DNA-based gut microbiota assessment and therapeutic efficacy of fecal microbiota transplantation in gastrointestinal diseases. Dig Dis. 2016;34:279–285.
   PubMed Web of Science ®Google Scholar
• Staley C, Kelly CR, Brandt LJ, et al. Complete microbiota engraftment is not essential for recovery from recurrent clostridium difficile infection following fecal microbiota transplantation. MBio. 2016;7.
   PubMed Web of Science ®Google Scholar
• ALSUntangled Group ALS untangled no. 21: fecal transplants. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:482–485.
   PubMed Web of Science ®Google Scholar
• Hodes RM. Fecal flora reconstitution for amyotrophic lateral sclerosis. J Clin Gastroenterol. 2013;47:655.
   PubMed Web of Science ®Google Scholar